Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD

European Respiratory Journal

Volumn 25, Issue 4, 2005, Pages 647-652

  Pons, A R ^a   Noguera, A ^a   Blanquer, D ^a   Sauleda, J ^a   Pons, J ^b   Agusti A G N ^a  

^a Inst Univ Invest Cie de la Salut   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

CD44; CD80; Chronic bronchitis; Emphysema; Human leukocyte antigen DR

Indexed keywords

B7 ANTIGEN; BRONCHODILATING AGENT; CD14 ANTIGEN; CD36 ANTIGEN; CD40 ANTIGEN; CD51 ANTIGEN; CD61 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; HERMES ANTIGEN; HLA DR ANTIGEN; STEROID;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BRONCHOSCOPY; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KRUSKAL WALLIS TEST; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG LAVAGE; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RANK SUM TEST; RESPIRATORY TRACT INFLAMMATION; SMOKING;

HUMANS; MACROPHAGES; MIDDLE AGED; MONOCYTES; PHENOTYPE; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CELL SURFACE;

EID: 17244375811     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00062304     Document Type: Article

References (43)

1. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd S, on behalf of the GOLD scientific committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 58: 832-834.
3. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-852.
4. Spiteri MA, Clarke SW, Polter LW. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur Respir J 1992; 5: 717-726.
5. Barbosa IL, Gant VA, Hamblin AS. Alveolar macrophages from patients with bronchogenic carcinoma and sarcoidosis similarly express monocyte antigens. Clin Exp Immunol 1991; 86: 173-178.
6. Somoskovi A, Zissel G, Ziegenhagen MW, Schlaak M, Muller-Quernheim J. Accessory function and costimulatory molecule expression of alveolar macrophages in patients with pulmonary tuberculosis. Immunobiology 2000; 201: 450-460.
7. Taylor ML, Noble PW, White B, Wise R, Liu MC, Bochner BS. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease. Clin Immunol 2000; 94: 33-41.
8. Striz I, Wang YM, Kalaycioglu O, Costabel U. Expression of alveolar macrophage adhesion molecules in pulmonary sarcoidosis. Chest 1992; 102: 882-886.
9. Viksman MY, Bochner BS, Stokes Peebles R, Schleimer RP, Liu PP. Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge. Clin Immunol 2002; 104: 77-85.
10. Viksman MY, Liu MC, Bickel CA, Schleimer RP, Bochner BS. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. Am J Respir Crit Care Med 1997; 155: 858-863.
11. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997; 52: 372-374.
12. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155: 852-857.
13. Russell RE, Culpitt SV, DeMatos C, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26: 602-609.
14. Culpitt SV, Rogers DF, Shah P, et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 24-31.
15. Sauleda J, Pons AR, Pons J, et al. Patients with chronic obstructive pulmonary disease showed decreased release of TIMP-1 and TGF- in cultured alveolar macrophages. Am J Respir Crit Care Med 2003; 167: A871.
16. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003; 8: 289-296.
17. Israel-Assayag E, Dakhama A, Lavigne S, Laviolette M, Cormier Y. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999; 159: 1830-1834.
18. Lensmar C, Elmberger G, Skold M, Eklund A. Smoking alters the phenotype of macrophages in induced sputum. Respir Med 1998; 92: 415-420.
19. Pankow W, Neumann K, Ruschoff J, Von Wichert P. Human alveolar macrophages: comparison of cell size, autofluorescence, and HLA-DR antigen expression in smokers and nonsmokers. Cancer Detect Prev 1995; 19: 268-273.
20. Khaldoyanidi S, Sikora L, Orlovskaya I, Matrosova V, Kozlov V, Sriramarao P. Correlation between nicotine-induced inhibition of hematopoiesis and decreased CD44 expression on bone marrow stromal cells. Blood 2001; 98: 303-312.
21. Hoosgsteden HC, van Hal PT, Wijkhuijs JM, Hop W, Verkaik AP, Hilvering C. Expression of the CD11/CD18 cell surface adhesion glycoprotein family on alveolar macrophages in smokers and nonsmokers. Chest 1991; 100: 1567-1571.
22. Schaberg T, Lauer C, Lode H, Fischer J, Haller H. Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis 1992; 146: 1287-1293.
23. Striz I, Wang YM, Scarcova I, Trnka L, Sorg C, Costabel U. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage. Eur Respir J 1993; 6: 1287-1294.
24. Skold CM, Lundahl J, Hallden G, Hallgren M, Eklund A. Chronic smoke exposure alters the phenotype pattern and the metabolic response in human alveolar macrophages. Clin Exp Immunol 1996; 106: 108-113.
25. Andreesen R, Brugger W, Scheibenbogen C, et al. Surface phenotype analysis of human monocyte to macrophage maturation. J Leukoc Biol 1990; 47: 490-497.
26. Rennard SI, Aalbers R, Bleecker E, et al. Bronchoalveolar lavage: performance, sampling procedure, processing and assessment. Eur Respir J 1998; 11: 13-15.
27. Wimberley NW, Bass JB Jr, Boyd BW, Kirkpatrick MB, Serio RA, Pollock HM. Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest 1982; 81: 556-562.
28. Katoh S, Matsubara Y, Taniguchi H, et al. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis. Clin Exp Immunol 2001; 126: 545-550.
29. Roca J, Sanchis J, Agustí-Vidal A, et al. Spirometric reference values for a mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
30. Prieto J, Eklund A, Patarroyo M. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol 1994; 156: 191-211.
31. Wahlstrom J, Berlin M, Sköld CM, Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999; 54: 339-346.
32. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: S29-S32.
33. Mokard D, Guery BP, Bouabdallah R, et al. Deactivation of alveolar macrophages in septic neutropenic ARDS. Chest 2003; 124: 644-652.
34. Muehlstedt SG, Lyte M, Rodriguez JL. Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pnemonia. Shock 2002; 17: 443-450.
35. Odeberg J, Soderberg-Naucler C. Reduced expression of HLA Class II molecules and interleukin-10 and transforming growth factor β1- independent supression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures. J Virol 2004; 75: 5174-5181.
36. Zhang P, Martin M, Yang QB, Michalek SM, Katz J. Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis. Infect Immun 2004; 72: 637-644.
37. Abbas A, Lichtman AH, Pober J. Effector mechanisms of cellular immunity. In: Cellular and Molecular Immunology. Philadelphia, WB Saunders, 2000; pp. 291-308.
38. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-1313.
39. McKee CM, Penno MB, Cowman M, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996; 98: 2403-2413.
40. Underhill CB, Nguyen HA, Shizari M, Culty M. CD44 positive macrophages take up hyaluronan during lung development. Dev Biol 1993; 155: 324-336.
41. Hart SP, Dougherty GJ, Haslett C, Dransfield I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J Immunol 1997; 159: 919-925.
42. Teder P, Vandivier RW, Jiang D, et al. Resolution of lung inflammation by CD44. Science 2002; 296: 155-158.
43. Noguera A, Sala E, Pons AR, Iglesias J, MacNee W, Agusti AGN. Expression of adhesion molecules during apoptosis of circulating neutrophils in chronic obstructive pulmonary disease. Chest 2004; 125: 1837-1842.